CYPHERPUNK TECHNOLOGIES INC. Accumulated Other Comprehensive Income
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Accumulated Other Comprehensive Income of -$81.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$81.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$86.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$95.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$104.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$81.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$86.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$95.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$104.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$82.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$113.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$120.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $6.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$120.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $106.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $760.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $414.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $355.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $128.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $690.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $94.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$425.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$267.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | -$246.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$449.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$564.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$579.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | -$87.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $121.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $988.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $76.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $327.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $322.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $278.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $302.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $160.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | -$19.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$158.00K 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | -$268.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$269.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $331.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$105.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $294.00K 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |